FMR LLC

FMR LLC has demonstrated a clear selling bias in recent months, with no recorded purchases across its disclosed holdings. The firm executed 19 sales totaling approximately $36.9 million, concentrated in two companies: Structure Therapeutics Inc. (GPCR) and Meta Materials Inc. (MTSR). The most significant activity occurred in GPCR, where FMR LLC conducted multiple sales on December 8, 2025, and January 15, 2026. The December transactions included several high-value disposals, such as a $1.02 million sale and a $954,626 sale, while the January sales were more varied in size, ranging from $1,701 to $547,262. These disposals suggest a measured reduction rather than a complete exit, as the sales were staggered across multiple filings. The firm’s activity in MTSR was comparatively limited, with only one notable sale of $11,817 on November 3, 2025, alongside several smaller transactions coded as gifts or other dispositions with no reported value. The absence of any buy transactions in the dataset, particularly against the backdrop of sustained selling, indicates a consistent divestment trend. While the reasons behind these sales remain undisclosed, the pattern reflects a deliberate reallocation away from these positions, with GPCR bearing the brunt of the sell-off in both frequency and dollar volume. The lack of purchases in the same period further underscores FMR LLC’s net reduction in exposure to these holdings.